CTS Tampa has implemented the Ortho Vitros Anti-SARS-CoV-2 Total test which qualitatively detects antibody (including IgG and IgM) to SARS-CoV-2 S protein on April 20, 2020. Additionally, Vitalant Research Institute is offering the SARS-CoV-2 Reporter Viral Particle Neutralization (RVPN) test.
The situation is rapidly developing and we know you likely have many questions, but you can find all the current information here: Communications
We will be sending updates as we get more details to share with you!
After a recent reevaluation of the Monolisa anti-HBs EIA package insert, the CTS QA/Scientific team ...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm. Th...
IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization
Reminder test emails for the Health and Human Services (HHS) email notifications for WNV reactives h...
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...
We sincerely hope to see you at this year’s AABB Annual Meeting in Boston, MA on October 12-16...